je.st
news
Tag: advanced
Top Utility-Scale Solar Contractor Selects Advanced Energy(R) Inverters for 325 MW of Solar Projects
2015-04-22 01:37:02| Semiconductors - Topix.net
Advanced Energy Industries, Inc. , a leader in precision power conversion solutions, today announced that it has been awarded 325 MW of solar projects by Swinerton Renewable Energy. The installation and commissioning of the portfolio of projects is expected to begin in 2015 and continue through the middle to end of 2016.
Tags: top
advanced
projects
contractor
Lectra to Highlight Advanced Furniture Solutions at High Point Market
2015-04-21 12:31:13| Industrial Newsroom - All News for Today
Visitors will learn about Lectra's end-to-end offer for upholstered furniture manufacturers ATLANTA - Lectra, the world leader in integrated technology solutions dedicated to industries using soft materials--fabrics, leather, technical textiles and composite materials--will showcase advanced technology solutions...
Tags: high
advanced
point
market
Johnson Controls 12V Lithium-ion battery for advanced start-stop vehicles debuts in China
2015-04-21 09:55:33| Green Car Congress
Tags: advanced
china
johnson
controls
Mircom Group of Companies Acquires Advanced Emergency Communications Company Metis Secure
2015-04-20 12:31:10| Industrial Newsroom - All News for Today
TORONTO The Mircom Group of Companies is pleased to announce the acquisition of advanced emergency communications company Metis Secure. The Metis Secure team will now be backed by Mircom's deep commitment to product development, manufacturing, and customer service. Located in Oakmont, PA, Metis Secure is an...
Tags: group
advanced
company
companies
Early Findings with KEYTRUDA (pembrolizumab), Mercks Anti-PD-1 Therapy, in Patients with Advanced Pleural Mesothelioma Presented at AACR Annual Meeting
2015-04-19 18:45:00| Merck.com - Product News
Dateline City: PHILADELPHIA KEYTRUDA Demonstrated 28 Percent Overall Response Rate and 76 Percent Disease Control Rate in Difficult-to-Treat Cancer First Findings from KEYNOTE-028, Mercks Innovative Basket Trial in 20 Cancers PHILADELPHIA--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in 25 patients with advanced pleural mesothelioma, a difficult-to-treat cancer of the lining of the lungs, abdomen and other organs. The early findings presented showed an overall response rate (confirmed and unconfirmed) of 28 percent with KEYTRUDA in patients with tumors that expressed PD-L1. Language: English Contact: Media:Pamela Eisele, 267-305-3558Claire Mulhearn, 908-236-1118orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
early
presented
meeting
Sites : [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] next »